Search Results - "WAGUESPACK, Steven G"

Beyond the “3 Ps”: A critical appraisal of the non-endocrine manifestations of multiple endocrine neoplasia type 1 by Waguespack, Steven G.

“…Multiple endocrine neoplasia type 1 (MEN1), an autosomal-dominantly inherited tumor syndrome, is classically defined by tumors arising from the “3 Ps”:…”
Get full text

Thyroid Sequelae of Pediatric Cancer Therapy by Waguespack, Steven G

“…The hypothalamic-pituitary-thyroid axis is a common site of unintended, acquired disease either during or after the treatment of cancer. Children treated with…”
Get more information

Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma by Wells, Jr, Samuel A, Asa, Sylvia L, Dralle, Henning, Elisei, Rossella, Evans, Douglas B, Gagel, Robert F, Lee, Nancy, Machens, Andreas, Moley, Jeffrey F, Pacini, Furio, Raue, Friedhelm, Frank-Raue, Karin, Robinson, Bruce, Rosenthal, M Sara, Santoro, Massimo, Schlumberger, Martin, Shah, Manisha, Waguespack, Steven G

“…The American Thyroid Association appointed a Task Force of experts to revise the original Medullary Thyroid Carcinoma: Management Guidelines of the American…”
Get more information

A comprehensive review on MEN2B by Castinetti, Frederic, Moley, Jeffrey, Mulligan, Lois, Waguespack, Steven G

“…MEN2B is a very rare autosomal dominant hereditary tumor syndrome associated with medullary thyroid carcinoma (MTC) in 100% cases, pheochromocytoma in 50%…”
Get full text

Risk of Neoplasia in Pediatric Patients Receiving Growth Hormone Therapy—A Report From the Pediatric Endocrine Society Drug and Therapeutics Committee by Raman, Sripriya, Grimberg, Adda, Waguespack, Steven G, Miller, Bradley S, Sklar, Charles A, Meacham, Lillian R, Patterson, Briana C

“…Context: GH and IGF-1 have been shown to affect tumor growth in vitro and in some animal models. This report summarizes the available evidence on whether GH…”
Get full text

Adrenocortical carcinoma: clinical outcomes and prognosis of 330 patients at a tertiary care center by Ayala-Ramirez, Montserrat, Jasim, Sina, Feng, Lei, Ejaz, Shamim, Deniz, Ferhat, Busaidy, Naifa, Waguespack, Steven G, Naing, Aung, Sircar, Kanishka, Wood, Christopher G, Pagliaro, Lance, Jimenez, Camilo, Vassilopoulou-Sellin, Rena, Habra, Mouhammed Amir

“…ObjectiveAdrenocortical carcinoma (ACC) is a rare malignancy with a poor prognosis. Herein, we describe the clinical features and outcomes for a large series…”
Get full text

Guidelines for surveillance of patients with von Hippel‐Lindau disease: Consensus statement of the International VHL Surveillance Guidelines Consortium and VHL Alliance by Daniels, Anthony B., Tirosh, Amit, Huntoon, Kristin, Mehta, Gautam U., Spiess, Philippe E., Friedman, Debra L., Waguespack, Steven G., Kilkelly, Jill E., Rednam, Surya, Pruthi, Sumit, Jonasch, Eric A., Baum, Laura, Chahoud, Jad

“…Von Hippel‐Lindau disease is a rare inherited cancer‐predisposition syndrome. The authors report the updated recommendations for the multiorgan surveillance…”
Get full text

Immune checkpoint inhibitor related hypophysitis: diagnostic criteria and recovery patterns by Nguyen, Ha, Shah, Komal, Waguespack, Steven G, Hu, Mimi I, Habra, Mouhammed Amir, Cabanillas, Maria E, Busaidy, Naifa L, Bassett, Roland, Zhou, Shouhao, Iyer, Priyanka C, Simmons, Garrett, Kaya, Diana, Pitteloud, Marie, Subudhi, Sumit K, Diab, Adi, Dadu, Ramona

“…Data on the diagnosis, natural course and management of immune checkpoint inhibitor (ICI)-related hypophysitis (irH) are limited. We propose this study to…”
Get full text

The Characterization of Pheochromocytoma and Its Impact on Overall Survival in Multiple Endocrine Neoplasia Type 2 by Thosani, Sonali, Ayala-Ramirez, Montserrat, Palmer, Lynn, Hu, Mimi I, Rich, Thereasa, Gagel, Robert F, Cote, Gilbert, Waguespack, Steven G, Habra, Mouhammed Amir, Jimenez, Camilo

“…Context: Pheochromocytoma (PHEO) occurs in 50% of patients with multiple endocrine neoplasia type 2 (MEN2). It is unknown if the presence of PHEO is associated…”
Get full text

Efficacy of pembrolizumab in patients with pituitary carcinoma: report of four cases from a phase II study by Majd, Nazanin, Waguespack, Steven G, Janku, Filip, Fu, Siqing, Penas-Prado, Marta, Xu, Mingxuan, Alshawa, Anas, Kamiya-Matsuoka, Carlos, Raza, Shaan M, McCutcheon, Ian E, Naing, Aung

“…Pituitary carcinoma is an aggressive tumor characterized by metastatic spread beyond the sellar region. Symptoms can be debilitating due to hormonal excess and…”
Get full text

Pediatric, Adolescent, and Young Adult Thyroid Carcinoma Harbors Frequent and Diverse Targetable Genomic Alterations, Including Kinase Fusions by Vanden Borre, Pierre, Schrock, Alexa B., Anderson, Peter M., Morris, John C., Heilmann, Andreas M., Holmes, Oliver, Wang, Kai, Johnson, Adrienne, Waguespack, Steven G., Ou, Sai‐Hong Ignatius, Khan, Saad, Fung, Kar‐Ming, Stephens, Philip J., Erlich, Rachel L., Miller, Vincent A., Ross, Jeffrey S., Ali, Siraj M.

“…Background Thyroid carcinoma, which is rare in pediatric patients (age 0–18 years) but more common in adolescent and young adult (AYA) patients (age 15–39…”
Get full text

Genetic profiling as a clinical tool in advanced parathyroid carcinoma by Kutahyalioglu, Merve, Nguyen, Ha T., Kwatampora, Lily, Clarke, Callisia, Silva, Angelica, Ibrahim, Eiman, Waguespack, Steven G., Cabanillas, Maria E., Jimenez, Camilo, Hu, Mimi I., Sherman, Steven I., Kopetz, Scott, Broaddus, Russell, Dadu, Ramona, Wanland, Kacey, Williams, Michelle, Zafereo, Mark, Perrier, Nancy, Busaidy, Naifa L.

“…Context Parathyroid carcinoma (PC) is a rare endocrine malignancy with no approved systemic therapies for unresectable locally invasive or distant metastatic…”
Get full text

Management of medullary thyroid carcinoma and MEN2 syndromes in childhood by Waguespack, Steven G, Rich, Thereasa A, Perrier, Nancy D, Jimenez, Camilo, Cote, Gilbert J

“…Medullary thyroid carcinoma is a rare endocrine malignancy that, when diagnosed during childhood, is almost always associated with multiple endocrine neoplasia…”
Get full text

Pediatric thyroid cancer guidelines: challenges in stratifying care based on limited data by Bauer, Andrew J, Wasserman, Jonathan D, Waguespack, Steven G

“…The 2022 European Thyroid Association Guidelines for the management of pediatric thyroid nodules and differentiated thyroid carcinoma (1) were developed by a…”
Get full text

Analytical and Clinical Validation of Expressed Variants and Fusions From the Whole Transcriptome of Thyroid FNA Samples by Angell, Trevor E., Wirth, Lori J., Cabanillas, Maria E., Shindo, Maisie L., Cibas, Edmund S., Babiarz, Joshua E., Hao, Yangyang, Kim, Su Yeon, Walsh, P. Sean, Huang, Jing, Kloos, Richard T., Kennedy, Giulia C., Waguespack, Steven G.

“…Introduction: The Afirma® Xpression Atlas (XA) detects gene variants and fusions in thyroid nodule FNA samples from a curated panel of 511 genes using…”
Get full text

Steroid Cell Ovarian Tumor in a Case of von Hippel-Lindau Disease: Demonstrating Lipid Content of the Mass with MR Imaging by Morani, Ajaykumar C., Mubarak, Ahmad Iyad, Bhosale, Hrishabh R., Ramani, Nisha S., Waguespack, Steven G., Ying, Anita

Get full text

Initial management and follow-up of differentiated thyroid cancer in children by Waguespack, Steven G, Francis, Gary

“…Children with differentiated thyroid cancer (DTC) often present with metastatic disease and have a high risk for recurrence, but rarely die of the disease…”
Get more information

Thyroid Dysfunction and Thyroid Cancer in Childhood Cancer Survivors: Prevalence, Surveillance and Management by Lebbink, Chantal A, Waguespack, Steven G, van Santen, Hanneke M

“…Childhood cancer survivors (CCS) are at increased risk of developing thyroid disorders during follow-up. Radiation therapy to a field that includes the thyroid…”
Get more information

Feasibility and outcome of re-irradiation in the treatment of multiply recurrent pituitary adenomas by Verma, Jonathan, McCutcheon, Ian E., Waguespack, Steven G., Mahajan, Anita

“…Purpose This study evaluates the toxicity and outcomes of re-irradiation to the sella for pituitary adenomas. Methods Patients diagnosed with a pituitary…”
Get full text

Recent Therapeutic Advances in Pituitary Carcinoma by Robertson, Ian J, Gregory, Timothy A, Waguespack, Steven G, Penas-Prado, Marta, Majd, Nazanin K

“…Pituitary carcinoma (PC) is a rare, aggressive malignancy that comprises 0.1-0.2% of all pituitary tumors. PC is defined anatomically as a pituitary tumor that…”
Get full text